Noveris Health Sciences (NVRS.CN)
19 transactions · range: 2021-10-01 → 2026-04-20 · last refreshed 2026-06-15T10:54
| Date | Insider | Type | Shares | Price | Value | Post-balance | Title |
|---|---|---|---|---|---|---|---|
| 2026-04-20 | — | Private Disposition | -3,047,900 | $1.10 | $-3,349,145 | 22,000 | |
| 2026-03-18 | Mr. David Joshua Bartch | Private Disposition | -6,797,900 | — | — | — | |
| 2026-03-18 | — | Private Acquisition | 3,047,900 | — | — | 22,000 | |
| 2026-03-06 | Mr. David Joshua Bartch | Derivative Exercise and Retained Stock | 6,797,900 | $0.14 | $961,420 | 6,805,419 | Co-Founder, Former CEO, President & Chairman of the Board |
| 2025-09-24 | Mr. David Joshua Bartch | Other Derivative Disposition | -1,240 | — | — | — | Co-Founder, Former CEO, President & Chairman of the Board |
| 2024-12-10 | — | Other Derivative Disposition | -15,982 | $556.88 | $-8,900,274 | 12,941 | |
| 2024-10-17 | Ray Van Empel | Open Market Disposition | -615 | $0.18 | $-111 | — | |
| 2024-10-17 | — | Open Market Disposition | -41,875 | $30.49 | $-1,276,587 | — | |
| 2024-01-08 | — | Open Market Acquisition | 12,000 | $1.31 | $15,707 | 22,000 | |
| 2024-01-04 | — | Open Market Acquisition | 10,000 | $1.12 | $11,232 | 10,000 | |
| 2023-10-17 | — | Private Acquisition | 20,000 | — | — | — | |
| 2023-05-08 | Mr. Damon Michaels | Open Market Disposition | -1,000 | $13.10 | $-13,102 | 1,818 | Co-Founder |
| 2023-04-11 | — | Open Market Disposition | -1,150 | $29.69 | $-34,141 | 21,651 | |
| 2022-09-14 | — | Open Market Acquisition | 17,260 | $22.03 | $380,289 | 21,651 | |
| 2022-02-03 | Mr. Todd Heinzl | Other Acquisition | 19 | $1,381.62 | $26,928 | — | Former Director |
| 2022-01-21 | — | Open Market Disposition | -303 | $578.31 | $-175,229 | 6,268 | |
| 2021-12-10 | — | Other Derivative Acquisition | 12,941 | $334.25 | $4,325,622 | 15,982 | |
| 2021-10-04 | Mr. Todd Heinzl | Open Market Acquisition | 73 | $1,390.47 | $101,657 | — | Former Director |
| 2021-10-01 | Dr. Rakesh Jetly | Open Market Acquisition | 2 | — | — | 84 | Chief Medical Officer |